Skip to content

Imaging the Duodenum Using an Optical Frequency Domain Imaging OFDI Capsule

Pilot Study for Imaging of the Duodenum Using an OFDI Capsule

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02202681
Enrollment
108
Registered
2014-07-29
Start date
2013-09-16
Completion date
2028-07-31
Last updated
2025-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Celiac Disease, Healthy

Keywords

Duodenum, Optical Frequency Domain Imaging (OFDI), Optical Coherence Tomography, Imaging, Celiac Disease

Brief summary

The study is being done to assess the tolerability and feasibility of a tethered OFDI capsule to image the duodenum. A total of 108 participants (36 healthy and 72 with clinically suspected or diagnosed Celiac disease) will be asked to swallow the tethered capsule, while they are awake and unsedated and ask for their feedback. Images will be taken using the OFDI system while the capsule travels from the esophagus into the stomach and into the duodenum.

Detailed description

Participants including healthy volunteers as well as patients with Celiac disease will be recruited and asked to swallow the OFDI capsule while being awake and unsedated. The capsule is attached to a tether which allows the operator to control as well as navigate the capsule as it progresses down the esophagus, through the stomach and into the duodenum using natural propulsive force called peristalsis. As the capsule progresses, multiple 2-dimensional cross-sectional images of the duodenum are acquired. Images are analyzed at a later stage.

Interventions

Imaging of the duodenum with the OFDI capsule and system

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participant must be over 18 years for healthy volunteers * Participants must be over 16 years for patients with Celiac disease * Participant must be able to give informed consent

Exclusion criteria

* Participants with an inability to swallow pills or capsules. * Participants with esophageal or intestinal fistulas. * Participants with known esophageal or intestinal strictures resulting in a luminal diameter smaller than the diameter of the capsule. * Participants with a history of intestinal Crohn's disease. * Women who are pregnant.

Design outcomes

Primary

MeasureTime frameDescription
Tolerability of OFDI Imaging in subjects swallowing the OFDI capsuleImages will be acquired during the OFDI imaging session which should on average take anywhere from 30 minutes to 2 hours.After participating in the study, the participant will be asked for feedback about tolerability of the procedure using a questionnaire.
Feasibility of OFDI Imaging in subjects swallowing the OFDI capsuleImages will be acquired during the OFDI imaging session which should on average take anywhere from 30 minutes to 2 hoursAn investigator will assess the quality of the recorded images and movies obtained with each exam after the imaging is completed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026